Globus Medical (GMED) Non-Current Deferred Tax Liability (2011 - 2026)
Globus Medical (GMED) posted Non-Current Deferred Tax Liability of $24.7 million for Q1 2026, up 3.8% on a QoQ basis from $23.8 million in Q4 2025, and down 47.09% year-over-year from $46.6 million in Q1 2025.
Globus Medical (GMED) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Globus Medical's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $24.7 million for Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 47.09% year-over-year to $24.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.7 million (down 47.09% YoY) and the FY2025 annual result came in at $23.8 million, down 0.56% from the prior year.
- Non-Current Deferred Tax Liability was $24.7 million for Q1 2026 at Globus Medical, up from $23.8 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $132.2 million in Q3 2023 and bottomed at $1.4 million in Q1 2023.
- A 5-year average of $27.9 million and a median of $23.8 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability surged 8277.12% — and 2024, when it sank 94.35%.
- Globus Medical's Non-Current Deferred Tax Liability stood at $1.8 million in 2022, then soared by 4645.42% to $84.4 million in 2023, then slumped by 71.7% to $23.9 million in 2024, then retreated by 0.56% to $23.8 million in 2025, then increased by 3.8% to $24.7 million in 2026.
- Business Quant data shows GMED's Non-Current Deferred Tax Liability at $24.7 million in Q1 2026, $23.8 million in Q4 2025, and $22.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.66 Mn |
| Mar 31, 2026 | 24.66 Mn |
| Dec 31, 2025 | 23.76 Mn |
| Dec 31, 2025 | 23.76 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Mar 31, 2025 | 46.61 Mn |
| Mar 31, 2025 | 46.61 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Sep 30, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.48 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Mar 31, 2024 | 39.95 Mn |
| Mar 31, 2024 | 39.95 Mn |
| Dec 31, 2023 | 84.42 Mn |
| Dec 31, 2023 | 84.42 Mn |